About POC infectious diseases
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. The testing site is usually a patient's bedside, physician's clinic, ICU, operating room, emergency room, or wherever medical care may be necessary. A healthcare professional or a nurse attending the patient will obtain the specimen, perform analysis, and record the result. The main purpose of POC testing is to decrease the time between diagnosis and treatment. This test is either antibody-based or microbial particle-based detection method, which includes ELISA, agglutination, optical immunoassays, or lateral flow immunochromatography. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies. Performing this test for screening infectious diseases extends its applications to the community practice setting. For instance, processing accurate data on the prevalence of influenza in community could help curtail inappropriate use of antibacterial agents and improve the allocation of vaccines to areas of highest need.
Technavio's analysts forecast the global POC infectious disease market to grow at a CAGR of 7.50% over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC infectious disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of testing kits and devices used for the major POC infectious diseases in the market. Based on diseases, the market can be divided into 10: flu, tuberculosis, malaria, RSV, adenovirus, infectious mononucleosis, fecal occult blood, HIV, strep. B, others (HCV, HBV, giardia, syphilis, and pneumonia).
Technavio's report, the Global POC Infectious Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global POC infectious disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Alere
• Meridian Bioscience
• Orasure Technologies
• Trinity Biotech
Other prominent vendors
• Abbott
• Beckman Coulter/ Danaher
• Becton Dickinson
• Biomerieux
• Bio-Rad
• Cepheid
• Diamedix
• Diasorin
• Eiken Chemical
• Enzo Biochem
• Fujirebio/ Innogenetics
• Grifols/ Novartis Diagnostics
• Humor Diagnostica
• Hologic/ Gen-Probe
• Nanogen/ Elitech
• Ortho-Clinical Diagnostics/ Johnson & Johnson
• Qiagen
• Roche Diagnostics
• SeraCare
• Siemens Healthcare
• Thermo Fisher Scientific
Market driver
• Increase in prevalence of infectious diseases
• For a full, detailed list, view our report
Market challenge
• Lack of awareness about POC devices
• For a full, detailed list, view our report
Market trend
• Shift from physician-centered to patient-centered model
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the Key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
3.1 Market overview
3.2 Product offerings
4 Market Research Methodology
4.1 Market research process
4.2 Research methodology
5 Introduction
6 Overview
7 Hospital-acquired Infections
8 Homecare Testing
8.1 Overview
8.2 Types of homecare
9 Market Landscape
9.1 Market overview
9.2 Market size and forecast
9.3 Five forces analysis
10 Market Segmentation by Diseases
10.1.1 RSV
10.1.2 Flu
10.1.3 Adenovirus
10.1.4 Malaria
10.1.5 Strep B
10.1.6 Tuberculosis
10.1.7 Fecal occult blood
10.1.8 HIV
10.1.9 Infectious mononucleosis
11 Geographical Segmentation
11.1 POC infectious diseases market in Americas
11.1.1 Market size and forecast
11.2 POC infectious diseases market in EMEA
11.2.1 Market size and forecast
11.3 POC infectious diseases market in APAC
11.3.1 Market size and forecast
12 Buying Criteria
13 Market Growth Drivers
14 Drivers and their Impact
15 Market Challenges
16 Impact of Drivers and Challenges
17 Market Trends
18 Trends and their Impact
19 Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.3 Other prominent vendors
20 Key Vendor Analysis
20.1 Alere
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation by revenue 2013
20.1.4 Business segmentation by revenue 2012 and 2013
20.1.5 Geographical segmentation by revenue 2013
20.1.6 Business strategy
20.1.7 Recent developments
20.1.8 SWOT analysis
20.2 Meridian
20.2.1 Key facts
20.2.2 Business overview
20.2.3 Business segmentation by revenue 2014
20.2.4 Business segmentation by revenue 2013 and 2014
20.2.5 Geographical segmentation by revenue 2014
20.2.6 Business strategy
20.2.7 Recent developments
20.2.8 SWOT analysis
20.3 OraSure
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Product segmentation
20.3.4 Business segmentation by revenue 2014
20.3.5 Business segmentation by revenue 2013 and 2014
20.3.6 Geographical segmentation by revenue 2014
20.3.7 Business strategy
20.3.8 Recent developments
20.3.9 SWOT analysis
20.4 Trinity Biotech
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2013
20.4.4 Business segmentation by revenue 2012 and 2013
20.4.5 Geographical segmentation by revenue 2013
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
21 Other Reports in this Series
List Of Exhibits
Exhibit 1: Market research methodology
Exhibit 2: POC testing market segmentation
Exhibit 3: Categorization of infectious diseases
Exhibit 4: HAIs in US
Exhibit 5: Estimated treatment cost and mortality associated with HAIs
Exhibit 6: Segmentation of HAI
Exhibit 7: Global POC infectious diseases market 2014-2019 ($ million)
Exhibit 8: Segmentation of market by disease types 2014
Exhibit 9: Regional malaria deaths
Exhibit 10: Regional malaria cases
Exhibit 11: WHO regional tuberculosis statistics
Exhibit 12: Demographic statistics for HIV
Exhibit 13: POC infectious diseases market by geography 2014
Exhibit 14: POC infectious diseases market by geography 2019
Exhibit 15: Segmentation of global POC infectious diseases market by geography 2014-2019
Exhibit 16: POC infectious diseases market in Americas 2014-2019 ($ million)
Exhibit 17: POC infectious diseases market in EMEA 2014-2019 ($ million)
Exhibit 18: POC infectious diseases market in APAC 2014-2019 ($ million)
Exhibit 19: Global POC Infectious Diseases Market: business segmentation by revenue 2013
Exhibit 20: Global POC Infectious Diseases Market: business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 21: Global POC Infectious Diseases Market: geographical segmentation by revenue 2013
Exhibit 22: Meridian: business segmentation by revenue 2014
Exhibit 23: Meridian: business segmentation by revenue 2013 and 2014 ($ million)
Exhibit 24: Meridian: geographical segmentation by revenue 2014
Exhibit 25: OraSure: product segmentation
Exhibit 26: OraSure: business segmentation by revenue 2014
Exhibit 27: OraSure: business segmentation by revenue 2013 and 2014 ($ million)
Exhibit 28: OraSure: geographical segmentation by revenue 2014
Exhibit 29: Trinity Biotech: business segmentation by revenue 2013
Exhibit 30: Trinity Biotech: business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 31: Trinity Biotech: geographical segmentation by revenue 2013
